Varian Inc.
Varian Inc. of Palo Alto, Calif., has
acquired Fourier transform mass spectrometry technology through its purchase of
IonSpec Corp. of Lake Forest, Calif. The technique is used in laboratories to discover
the function and structural characterization of proteins and other biomolecules.
The information provides scientists with fundamental knowledge of how cells work
and how diseases evolve, leading to new diagnostic research and drug targets. The
company expects the agreement to facilitate the expansion of its technology portfolio
and to increase participation in the study of proteins, nucleic acids and drug metabolites.
LATEST NEWS
- Nicslab’s Fabless Chip Technology Earns First Place at Luminate 2024
Sep 27, 2024
- Marvel Fusion Closes $70M Funding Round: Week in Brief: 9/27/24
Sep 27, 2024
- Silicon Photonic Modulator Enables Atom Interferometry
Sep 27, 2024
- Method Measures Trapped Qubits While Keeping Others Safe, Close
Sep 26, 2024
- Industrial Laser-Driven Neutron Source Developed for Nondestructive Assessment of Nuclear Waste
Sep 26, 2024
- Glass-Based PICs Developer Expands Following NATO-Supported Funding
Sep 25, 2024
- InZiv Appoints Vice President of R&D: People in the News: 9/25/24
Sep 25, 2024
- Ansys, TSMC, Collaborate with Microsoft on High-Speed Optical Data Transfer
Sep 25, 2024